BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9234946)

  • 1. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.
    Morling FJ; Peng KW; Cosset FL; Russell SJ
    Virology; 1997 Jul; 234(1):51-61. PubMed ID: 9234946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding.
    Valsesia-Wittmann S; Morling FJ; Hatziioannou T; Russell SJ; Cosset FL
    EMBO J; 1997 Mar; 16(6):1214-23. PubMed ID: 9135138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.
    Schnierle BS; Moritz D; Jeschke M; Groner B
    Gene Ther; 1996 Apr; 3(4):334-42. PubMed ID: 8732165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU.
    Valsesia-Wittmann S; Morling FJ; Nilson BH; Takeuchi Y; Russell SJ; Cosset FL
    J Virol; 1996 Mar; 70(3):2059-64. PubMed ID: 8627737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the putative receptor-binding domain of Moloney murine leukemia virus glycoprotein gp70.
    Panda BR; Kingsman SM; Kingsman AJ
    Virology; 2000 Jul; 273(1):90-100. PubMed ID: 10891411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable regions A and B in the envelope glycoproteins of feline leukemia virus subgroup B and amphotropic murine leukemia virus interact with discrete receptor domains.
    Tailor CS; Kabat D
    J Virol; 1997 Dec; 71(12):9383-91. PubMed ID: 9371598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of a 14-amino-acid peptide essential for the interaction between the murine leukemia virus amphotropic envelope glycoprotein and its receptor.
    Battini JL; Danos O; Heard JM
    J Virol; 1998 Jan; 72(1):428-35. PubMed ID: 9420242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope.
    Lam JS; Reeves ME; Cowherd R; Rosenberg SA; Hwu P
    Hum Gene Ther; 1996 Aug; 7(12):1415-22. PubMed ID: 8844200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral retargeting by envelopes expressing an N-terminal binding domain.
    Cosset FL; Morling FJ; Takeuchi Y; Weiss RA; Collins MK; Russell SJ
    J Virol; 1995 Oct; 69(10):6314-22. PubMed ID: 7666532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of retroviral tropism by display of IGF-I.
    Chadwick MP; Morling FJ; Cosset FL; Russell SJ
    J Mol Biol; 1999 Jan; 285(2):485-94. PubMed ID: 9878423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins.
    Maurice M; Mazur S; Bullough FJ; Salvetti A; Collins MK; Russell SJ; Cosset FL
    Blood; 1999 Jul; 94(2):401-10. PubMed ID: 10397706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters.
    Kavanaugh MP; Miller DG; Zhang W; Law W; Kozak SL; Kabat D; Miller AD
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7071-5. PubMed ID: 8041748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein.
    Suzuki S; Shimada T
    Biochem Biophys Res Commun; 2000 May; 271(3):672-6. PubMed ID: 10814520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene delivery system activatable by disease-associated matrix metalloproteinases.
    Peng KW; Morling FJ; Cosset FL; Murphy G; Russell SJ
    Hum Gene Ther; 1997 Apr; 8(6):729-38. PubMed ID: 9113512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry.
    Viejo-Borbolla A; Pizzato M; Blair ED; Schulz TF
    Virus Res; 2005 Mar; 108(1-2):45-55. PubMed ID: 15681054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.
    Sugai J; Eiden M; Anderson MM; Van Hoeven N; Meiering CD; Overbaugh J
    J Virol; 2001 Aug; 75(15):6841-9. PubMed ID: 11435563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of retroviral vectors through protease-substrate interactions.
    Nilson BH; Morling FJ; Cosset FL; Russell SJ
    Gene Ther; 1996 Apr; 3(4):280-6. PubMed ID: 8732159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of N-linked glycosylation in the activity of the Friend murine leukemia virus SU protein receptor-binding domain.
    Battini JL; Kayman SC; Pinter A; Heard JM; Danos O
    Virology; 1994 Jul; 202(1):496-9. PubMed ID: 8009864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of regions in the Moloney murine leukemia virus SU protein that tolerate the insertion of an integrin-binding peptide.
    Wu BW; Lu J; Gallaher TK; Anderson WF; Cannon PM
    Virology; 2000 Mar; 269(1):7-17. PubMed ID: 10725193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.